TORONTO — Licensed marijuana producer Bedrocan is slashing the price of all six of its medical cannabis strains to $5 a gram, citing a desire to make medicine more affordable for patients.
The company's products previously cost $7.50 a gram.
Bedrocan Canada Inc. is a subsidiary of Canopy Growth Corp. (TSXV:CGC), a combined company formed when Bedrocan merged with Tweed Marijuana Inc.
Bedrocan president Marc Wayne says the company will still be able to turn a profit, even after price cuts that amount to roughly 33 per cent.
"We're very good at producing cannabis at a low cost," said Wayne.
"After spending the last six months perfecting production techniques in Canada from our Dutch partners in Holland, we now have the ability to reduce our cost."
.jpg "Science of Cocktails Molecular Mixology meets the Laboratory of Libations")
